GlaxoSmithKline (GSKL)

1,771.50p
   
  • Change Today:
    -0.085p
  • 52 Week High: 1,812.75
  • 52 Week Low: 1,313.60
  • Currency: UK Pounds
  • Shares Issued: 4,870.09m
  • Volume: 884,737
  • Market Cap: £86,274m

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Mar-24 31-Mar-23 31-Mar-22 31-Mar-21 31-Mar-20
Continuing Operations          
Revenue 7,363.00 6,951.00 7,190.00 7,418.00 7,418.00
Operating Profit/(Loss) 1,490.00 2,082.00 2,293.00 1,693.00 1,693.00
Profit Before Tax 1,355.00 1,907.00 2,094.00 1,518.00 1,518.00
Profit After Tax 1,081.00 1,631.00 1,771.00 1,260.00 1,260.00
Discontinued Operations          
Profit After Tax n/a n/a 396.00 n/a n/a
PROFIT FOR THE PERIOD 1,081.00 1,631.00 2,167.00 1,260.00 1,260.00
           
Continuing EPS          
Earnings per Share - Basic 25.70p 36.80p 37.30p 21.50p 21.50p
Earnings per Share - Diluted 25.40p 36.50p 36.90p 21.30p 21.30p
Earnings per Share - Adjusted 43.10p 37.00p 32.30p 22.90p 22.90p
Continuing and Discontinued EPS          
Earnings per Share - Basic 25.70p 36.80p 37.30p 21.50p 21.50p
Earnings per Share - Diluted 25.40p 36.50p 36.90p 21.30p 21.30p
Earnings per Share - Adjusted 43.10p 37.00p 32.30p 22.90p 22.90p
Dividend per Share 15.00p 14.00p 17.50p 19.00p 19.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Mar-24 31-Mar-23 31-Mar-22 31-Mar-21 31-Mar-20
Total Non-Current Assets 41,306.00 38,877.00 39,377.00 59,555.00 60,429.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 58,511.00 58,596.00 60,146.00 78,079.00 79,103.00
Total Liabilities 45,282.00 47,284.00 50,050.00 57,069.00 57,761.00
Net Assets 13,229.00 11,312.00 10,096.00 21,010.00 21,342.00
           
Shareholders Funds 13,840.00 13,347.00 10,598.00 14,865.00 15,055.00
Minority Interests/Other Equity (611.00) (552.00) (502.00) 6,145.00 6,287.00
Total Equity 13,229.00 11,312.00 10,096.00 21,010.00 21,342.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page